NCT01769885 2022-08-15Tivozanib Before Surgery in Treating Patients With Localized Kidney CancerRoswell Park Cancer InstitutePhase NA Withdrawn
NCT01369433 2020-09-01A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsAVEO Pharmaceuticals, Inc.Phase NA Terminated225 enrolled 7 charts